 Canadian Health Minister Leona Aglukkaq announced on June 5, 2012 that MDPV would be listed on Schedule I of the Controlled Drugs and Substances Act, which was realized on September 26, 2012.In the United States, MDPV is a DEA federally scheduled drug.On October 21, 2011, the DEA issued a temporary one-year ban on MDPV, classifying it as a schedule I substance.